Trouble reading this email? View it in your browser
European Federation of Pharmaceutical industries and associations
   

EFPIA Newsletter 22 September 2022

 
 
 
   

News

 

EFPIA and the EFPIA Oncology Platform Congratulate the European Commission on its proposal...
20 September 2022

The Commission’s proposal is an important step forward to ensure people across Europe benefit from the latest innovation... Read more

 
 
 
   

Blogs

 

Improving Understanding of Epidemiology and Impact of Alzheimer’s Disease
21 September 2022

World Alzheimer's Day Read more

Success of Paediatric Regulation inspires us to go further (Guest blog)
21 September 2022 - Victoria Kitcatt

Review is an opportunity to embrace ‘child-centred’ approach Read more

Diabetes & data: can digitalization unlock better care?
20 September 2022 - Sophie Noya

The proposed European Health Data Space (EHDS) is an opportunity to build registries, support mobility and improve outcomes... Read more

 
 
 
   

Events

 

Reducing health inequalities: cancer care as a blueprint
27 September 2022 (European Health Forum Gastein (EHFG))

Organised by the EFPIA Oncology Platform, European Cancer Organisation & European Cancer Patient Coalition Read more

Pharmaceutical strategy for Europe – implementation, achievements, challenges
29 September 2022 (Brussels)

Event held under the auspices of the Czech Presidency of the Council of the EU. Read more

Women’s Brain Project webinar II
06 October 2022 (Virtual event)

Because our brains and mental health deserve precision medicine for the greater good Read more

EU HEALTH SUMMIT 2022: TOWARDS AN EU HEALTH UNION
15 November 2022 (Brussels)

An EU Health Coalition event Read more

 
 
 
   

What we are reading

 
Securing Europe’s competitiveness: Addressing its technology gap
On 22 September 2022 (McKinsey)

Europe needs to pay attention to its slow-motion corporate and technology crisis. Read more

Pharma Firms Lament Inconsistencies In EU Blood, Tissues & Cells Proposal
On 19 September 2022 (Pink Sheet)

Stakeholders have suggested changes to the draft EU regulation on substances of human origin to ensure there is no interference... Read more